Sandbox sowminya: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
 
(35 intermediate revisions by the same user not shown)
Line 1: Line 1:


<div style="font-size: 90%;">
{{Familytree/start}}
{{Familytree|boxstyle=border: 0;| | | | | | | | | | A01 | | | | | | | | | | |A01={{F1|B-cell neoplasms}}}}
{{Familytree|boxstyle=border: 0;| | | | | |,|-|-|-|-|^|-|-|-|-|.| | | | | | |}}
{{Familytree|boxstyle=border: 0;| | | | | B01 | | | | | | | | B02 | | | | | |B01={{F1|CD5+}}|B02={{F1|CD5-}}}}
{{Familytree|boxstyle=border: 0;| | |,|-|-|^|-|-|.| | | | | | |!| | | | | | |}}
{{Familytree|boxstyle=border: 0;| | C01 | | | | C02 | | | | | C03 | | | | | |C01={{F1|CCND1+}}|C02={{F1|CCND1-}}|C03={{F1|DLBCL}}}}
{{Familytree|boxstyle=border: 0;| | |!| | | | | |!| | | |,|-|-|^|-|-|-|-|-|-|.| | | |}}
{{Familytree|boxstyle=border: 0;| | D01 | | | | D02 | | D03 | | | | | | | | D04 | | |D01={{F2|Pleomorphic MCL}}|D02={{F2|DLBCL, NOS CD5+}}|D03={{F1|CD10+}}|D04={{F1|CD10-}}}}
{{Familytree|boxstyle=border: 0;| | | | | | | | | | | | |!| | | | | | | | | |!| | | |}}
{{Familytree|boxstyle=border: 0;| | | | | | | | | | | | E01 | | | | |,|-|-|-|+|-|-|-|.| | | |E01={{F2|DLBCL, NOS GCB type}}}}
{{Familytree|boxstyle=border: 0;| | | | | | | | | | | | | | | | | | F01 | | F02 | | F03 | | |F01={{F1|BCL6+ IRF4/MUM1-}}|F02={{F1|BCL6+ IRF4/MUM1+}}|F03={{F1|BCL6- IRF4/MUM1+}}}}
{{Familytree|boxstyle=border: 0;| | | | | | | | | | | | | | | | | | |!| | | |!| | | |!| | | |}}
{{Familytree|boxstyle=border: 0;| | | | | | | | | | | | | | | | | | G01 | | G02 | | G03 | | |G01={{F2|DLBCL, NOS GCB type}}|G02={{F2|Non-GCB}}|G03={{F2|Post-GCB}}}}
{{Familytree/end}}
</div>
===Use of Immunophenotyping/Genetic Testing in Differential Diagnosis of Mature B-Cell and NK/T-Cell Neoplasms===


<div style="font-size: 80%;"><BR>
{{Familytree/start}}
{{Familytree/start}}
{{Familytree|boxstyle=border: 0;| | | | | | A01 | | | | | | | | | | |A01={{F1|Age ≥ 55 or ⊕ alarm features?}}}}
{{Familytree|boxstyle=border: 0;| | | | | | | | | | A01 | | | | | | | | | | |A01={{F1|B-cell neoplasms}}}}
{{Familytree|boxstyle=border: 0;| |,|-|-|-|-|^|-|-|-|-|.| | | | | | |}}
{{Familytree|boxstyle=border: 0;| | | | | |,|-|-|-|-|^|-|-|-|-|.| | | | | | |}}
{{Familytree|boxstyle=border: 0;| B01 | | | | | | | | B02 | | | | | |B01={{F1|YES}}|B02={{F1|NO}}}}
{{Familytree|boxstyle=border: 0;| | | | | B01 | | | | | | | | B02 | | | | | |B01={{F1|CD5+}}|B02={{F1|CD5-}}}}
{{Familytree|boxstyle=border: 0;| |!| | | | | | | | | |!| | | | | | |}}
{{Familytree|boxstyle=border: 0;| | |,|-|-|^|-|-|.| | | | | | |!| | | | | | |}}
{{Familytree|boxstyle=border: 0;| C01 | | | | | | | | C02 | | | | | |C01={{F2|Endoscopy}}|C02={{F1|''H. pylori'' prevalence?}}}}
{{Familytree|boxstyle=border: 0;| | C01 | | | | C02 | | | | | C03 | | | | | |C01={{F1|CCND1+}}|C02={{F1|CCND1-}}|C03={{F1|DLBCL}}}}
{{Familytree|boxstyle=border: 0;| |!| | | | |,|-|-|-|-|^|-|-|-|-|.| |}}
{{Familytree|boxstyle=border: 0;| | |!| | | | | |!| | | |,|-|-|^|-|-|-|-|-|-|.| | | |}}
{{Familytree|boxstyle=border: 0;| |!| | | | D01 | | | | | | | | D02 |D01={{F1|High}}|D02={{F1|Low}}}}
{{Familytree|boxstyle=border: 0;| | D01 | | | | D02 | | D03 | | | | | | | | D04 | | |D01={{F2|Pleomorphic MCL}}|D02={{F2|DLBCL, NOS CD5+}}|D03={{F1|CD10+}}|D04={{F1|CD10-}}}}
{{Familytree|boxstyle=border: 0;| |!| | | | |!| | | | | | | | | |!| |}}
{{Familytree|boxstyle=border: 0;| | | | | | | | | | | | |!| | | | | | | | | |!| | | |}}
{{Familytree|boxstyle=border: 0;| |!| | | | E01 | | | | | | | | E02 |E01={{F2|Test-and-treat strategy ± acid suppression}}|E02={{F2|Acid suppression trial}}}}
{{Familytree|boxstyle=border: 0;| | | | | | | | | | | | E01 | | | | |,|-|-|-|+|-|-|-|.| | | |E01={{F2|DLBCL, NOS GCB type}}}}
{{Familytree|boxstyle=border: 0;| |`|-|-|-|-|+|-|-|-|-|-|-|-|-|-|'| |}}
{{Familytree|boxstyle=border: 0;| | | | | | | | | | | | | | | | | | F01 | | F02 | | F03 | | |F01={{F1|BCL6+ IRF4/MUM1-}}|F02={{F1|BCL6+ IRF4/MUM1+}}|F03={{F1|BCL6- IRF4/MUM1+}}}}
{{Familytree|boxstyle=border: 0;| | | | | | F01 | | | | | | | | | | |F01={{F1|If eradication therapy is indicated}}}}
{{Familytree|boxstyle=border: 0;| | | | | | | | | | | | | | | | | | |!| | | |!| | | |!| | | |}}
{{Familytree|boxstyle=border: 0;| |,|-|-|-|-|^|-|-|-|-|.| | | | | | |}}
{{Familytree|boxstyle=border: 0;| | | | | | | | | | | | | | | | | | G01 | | G02 | | G03 | | |G01={{F2|DLBCL, NOS GCB type}}|G02={{F2|Non-GCB}}|G03={{F2|Post-GCB}}}}
{{Familytree|boxstyle=border: 0;| G01 | | | | | | | | G02 | | | | | |G01={{F1|Clarithromycin resistance ≥ 20%}}|G02={{F1|Clarithromycin resistance < 20%}}}}
{{Familytree|boxstyle=border: 0;| |!| | | | | | | | | |!| | | | | | |}}
{{Familytree|boxstyle=border: 0;| H01 | | | | | | | | H02 | | | | | |H01={{F2|Quadruple or sequential therapy}}|H02={{F2|PCA or PCM or Bismuth quadruple therapy}}}}
{{Familytree|boxstyle=border: 0;| |!| | | | | | | | | |!| | | | | | |}}
{{Familytree|boxstyle=border: 0;| I01 | | | | | | | | I02 | | | | | |I01={{F2|PLA}}|I02={{F2|Bismuth quadruple therapy or PLA}}}}
{{Familytree|boxstyle=border: 0;| |`|-|-|-|-|v|-|-|-|-|'| | | | | | |}}
{{Familytree|boxstyle=border: 0;| | | | | | J01 | | | | | | | | | | |J01={{F1|Adjust Rx per susceptibility test}}}}
{{Familytree|boxstyle=border: 0;| | | | | | |!| | | | | | | | | | | |}}
{{Familytree|boxstyle=border: 0;| | | | | | K01 | | | | | | | | | | |K01={{F2|Consider endoscopy if treatment fails}}}}
{{Familytree/end}}
{{Familytree/end}}
</div>
</div>

Latest revision as of 20:06, 23 March 2016

 
 
 
 
 
 
 
 
 
B-cell neoplasms
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CD5+
 
 
 
 
 
 
 
CD5-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CCND1+
 
 
 
CCND1-
 
 
 
 
DLBCL
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pleomorphic MCL
 
 
 
DLBCL, NOS CD5+
 
CD10+
 
 
 
 
 
 
 
CD10-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DLBCL, NOS GCB type
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BCL6+ IRF4/MUM1-
 
BCL6+ IRF4/MUM1+
 
BCL6- IRF4/MUM1+
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DLBCL, NOS GCB type
 
Non-GCB
 
Post-GCB
 
 



Use of Immunophenotyping/Genetic Testing in Differential Diagnosis of Mature B-Cell and NK/T-Cell Neoplasms


 
 
 
 
 
 
 
 
 
B-cell neoplasms
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CD5+
 
 
 
 
 
 
 
CD5-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CCND1+
 
 
 
CCND1-
 
 
 
 
DLBCL
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pleomorphic MCL
 
 
 
DLBCL, NOS CD5+
 
CD10+
 
 
 
 
 
 
 
CD10-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DLBCL, NOS GCB type
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BCL6+ IRF4/MUM1-
 
BCL6+ IRF4/MUM1+
 
BCL6- IRF4/MUM1+
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DLBCL, NOS GCB type
 
Non-GCB
 
Post-GCB
 
 
Retrieved from "https://www.wikidoc.org/index.php?title=Sandbox_sowminya&oldid=1228328"